Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT

Bone Marrow Transplant. 2024 Jul;59(7):1034-1036. doi: 10.1038/s41409-024-02279-2. Epub 2024 Apr 11.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Female
  • France
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Male
  • Middle Aged
  • Thrombotic Microangiopathies* / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • eculizumab